Evidence map›Paper›PMID 37323815›Full record

ArticleOncology letters2023

Effect of HER2 expression status on the prognosis of patients with HR

Kan Wang, Qinglei Du, Jie Yu, Yao Li, Xulong Zhu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kan WangDepartment of Surgical Oncology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China.
Qinglei DuDepartment of Hematology Oncology and Nephrology, The Nuclear Industry 417 Hospital, Xi'an, Shaanxi 710600, P.R. China.
Jie YuDepartment of Hematology Oncology and Nephrology, The Nuclear Industry 417 Hospital, Xi'an, Shaanxi 710600, P.R. China.
Yao LiDepartment of Hematology Oncology and Nephrology, The Nuclear Industry 417 Hospital, Xi'an, Shaanxi 710600, P.R. China.
Xulong ZhuDepartment of Surgical Oncology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068, P.R. China.
Shaanxi Provincial People's Hospital · CNShanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to retrospectively assess the effects of human epidermal growth factor receptor 2 (HER2) expression on the diagnosis of patients with hormone receptor (HR)

Indexed as

advanced breast cancerendocrine therapyhuman epidermal growth factor receptor 2overall survivalprogression-free survival

Identifiers

PMID37323815
PMCPMC10265361
OpenAlexW4378376488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.